Verastem names Daniel Paterson COO
This article was originally published in Scrip
Verastem, a company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, has appointed Daniel Paterson, current chief business officer, to the role of chief operating officer. Mr Paterson has been at Verastem since 2012, initially joining the company as a consultant. Prior to working at Verastem, he was COO of On-Q-ity following its acquisition of The DNA Repair Company where he was the CEO and president from 2006.
You may also be interested in...
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.